Lloyd Marcea Bland
Related Filers (2)
Ownership (19)
4
Thursday, 6/16/2022
Poseida Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/26/2021
Poseida Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/17/2021
Poseida Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/15/2020
Poseida Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/13/2020
Poseida Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/9/2020
Poseida Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 8/10/2012
AMYLIN PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/7/2012
AMYLIN PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 3/2/2012
AMYLIN PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 2/24/2012
AMYLIN PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 2/10/2012
AMYLIN PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 1/12/2012
AMYLIN PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 3/3/2011
AMYLIN PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 2/4/2010
AMYLIN PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 3/6/2009
AMYLIN PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 2/5/2009
AMYLIN PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 3/6/2008
AMYLIN PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/5/2008
AMYLIN PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3
Thursday, 2/8/2007
AMYLIN PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities